Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain

Drugs under Experimental and Clinical Research

Volumn 26, Issue 5-6, 2000, Pages 239-247

  Uglyanitsa, K N ^a   Nefyodov, L I ^a   Karayedova, L M ^a   Nowicky, J W ^a   Brzosko, W ^a  

^a INSTITUTE OF BIOCHEMISTRY   (Belarus)

Author keywords

[No Author keywords available]

Indexed keywords

UKRAIN;

ARTICLE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ALKALOIDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BERBERINE ALKALOIDS; BLOOD CELL COUNT; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNITY, CELLULAR; INJECTIONS, INTRAVENOUS; MACROPHAGES; NAD; PHENANTHRIDINES;

EID: 0034447409     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Biological properties of Ukrain in experimental and clinical investigation
2. Chelidonium majus L. (Ukrain) in the treatment of cancer patients
3. Influence of Ukrain on patients with surgically treated breast cancer
4. Influence of Ukrain on breast cancer
5. Influence of Ukrain on patients with surgically treated breast cancer. Part I. Clinical and laboratory parameters
6. Influence of Ukrain on patients with surgically treated breast cancer. Part II. Hormonal profile
7. Influence of Ukrain on patients with surgically treated breast cancer. Part III. The immune system
8. Influence of Ukrain on patients with surgically treated breast cancer. Part IV. Electromicroscopic and cytochemical evaluation
9. Amino acids and their derivatives in tumor tissue from patients with breast cancer treated with Ukrain (Part VI)
10. Amino acids and their derivatives in blood plasma of patients with breast cancer treated with Ukrain (Part V)